We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Breast cancer treatment and follow-up management during COVID-19 pandemic.
- Authors
Luminita Zob, Daniela; Lucia Stănculeanu, Dana; Drăgănescu, Mădălina; Mazilu, Laura; Nitipir, Cornelia; Constantinescu, Amalia; Niculai, Gabriela; Silvana Gheorghe, Adelina; Gheorghe, Andreea-Daniela; Blidaru, Alexandru
- Abstract
Breast cancer is the leading cause of cancer in women worldwide and the second cause of cancer in both sexes. In Romania, it is the leading cause of cancer, according to Cancer Country Profile 2020. Some breast cancer treatments – including chemotherapy, targeted therapies and radiation – can weaken the immune system. People with weakened immune systems or lung problems due to radiotherapy pneumonitis or with lung metastases have a much higher risk of complications if they are infected with SARS-CoV-2. On the 20th of April 2020, there were reported 2,444,209 coronavirus cases and 167,986 deaths. There are various recommendations amidst COVID-19 pandemic on the diagnostic and treatment of patients with different kinds of solid tumors. Almost all professional societies try to identify the optimal protocols for cancer facilities, to minimize the risk of SARS-CoV-2 infection in both inpatient and outpatient settings. Due to the coronavirus pandemic, routine checkups, elective, unnecessary surgeries and other procedures have been cut back or delayed to help minimize exposure to the virus which has already infected more than 2.4 million people. The recommendations were divided according to the phase of pandemic manifestations on different countries and according to priority. In this review, we want to reinforce and bring together all recommendations made by different societies involved in the treatment management of breast cancer patients, because this pandemic led to new ways of dealing cancer patients.
- Subjects
ROMANIA; COVID-19 pandemic; BREAST cancer; CANCER treatment; RADIOTHERAPY; CANCER patients; TRIPLE-negative breast cancer
- Publication
Oncolog-Hematolog, 2020, Issue 51, p34
- ISSN
2066-8716
- Publication type
Article
- DOI
10.26416/onhe.51.2.2020.3192